Bigfoot Biomedical
Milpitas
About Bigfoot Biomedical
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $204.6M
- Funding stage: M&A
- Last round: Convertible Note (Aug 2022)
- Website: bigfootbiomedical.com
- Phone: 408-716-5600
Industries & Categories
Artificial Intelligence (AI), Big Data, Diabetes, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bigfoot-biomedical-59552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.